K. Trewhitt

A phase II study of durvalumab, a PD-L1 inhibitor and olaparib in recurrent ovarian cancer (OvCa).

E. Kohn, L. Minasian, J. Trepel, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone marrow aspiration and biopsy: collection and interpretation.

K. Trewhitt, 2001, Oncology nursing forum.